Receptors, CXCR3

Home
About
Help
History (1)
- Receptors, CXCR3
- See All Pages

"Receptors, CXCR3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

CXCR receptors that are expressed on the surface of a number of cell types, including T-LYMPHOCYTES; NK CELLS; DENDRITIC CELLS; and a subset of B-LYMPHOCYTES. The receptors are activated by CHEMOKINE CXCL9; CHEMOKINE CXCL10; and CHEMOKINE CXCL11.

Descriptor ID	D054367
MeSH Number(s)	D12.776.543.750.695.160.500.300 D12.776.543.750.705.852.125.500.300
Concept/Terms	Receptors, CXCR3 Receptors, CXCR3 CXCR3 Receptor Receptor, CXCR3 CXC Chemokine Receptor 3 CD183 Antigens Antigens, CD183 CXCR3 Receptors Chemokine (C-C Motif) Receptor 3 CMKBR3 Chemokine Receptors Chemokine Receptors, CMKBR3 Receptors, CMKBR3 Chemokine CXC Chemokine Receptors 3

Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, G-Protein-Coupled [D12.776.543.750.695]
Receptors, Chemokine [D12.776.543.750.695.160]
Receptors, CXCR [D12.776.543.750.695.160.500]
Receptors, CXCR3 [D12.776.543.750.695.160.500.300]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Chemokine [D12.776.543.750.705.852.125]
Receptors, CXCR [D12.776.543.750.705.852.125.500]
Receptors, CXCR3 [D12.776.543.750.705.852.125.500.300]

Below are MeSH descriptors whose meaning is related to "Receptors, CXCR3".

Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, CXCR3" by people in this website by year, and whether "Receptors, CXCR3" was a major or minor topic of these publications.

Bar chart showing 22 publications over 12 distinct years, with a maximum of 4 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	1	1
2007	0	1	1
2008	1	1	2
2011	1	0	1
2012	1	1	2
2013	0	1	1
2014	2	1	3
2017	3	0	3
2019	1	1	2
2020	1	3	4
2022	0	1	1
2023	0	1	1

Below are the most recent publications written about "Receptors, CXCR3" by people in Profiles.

Richmond JM, Patel D, Watanabe T, Chen HW, Martyanov V, Werner G, Garg M, Haddadi NS, Refat MA, Mahmoud BH, Wong LD, Dresser K, Deng A, Zhu JL, McAlpine W, Hosler GA, Feghali-Bostwick CA, Whitfield ML, Harris JE, Torok KS, Jacobe HT. CXCL9 Links Skin Inflammation and Fibrosis through CXCR3-Dependent Upregulation of Col1a1 in Fibroblasts. J Invest Dermatol. 2023 07; 143(7):1138-1146.e12.

View in: PubMed
Tib?rcio R, Narendran G, Barreto-Duarte B, Queiroz ATL, Ara?jo-Pereira M, Anbalagan S, Nayak K, Ravichandran N, Subramani R, Antonelli LRV, Satagopan K, Anbalagan K, Porter BO, Sher A, Swaminathan S, Sereti I, Andrade BB. Frequency of CXCR3+ CD8+ T-Lymphocyte Subsets in Peripheral Blood Is Associated With the Risk of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Development in Advanced HIV Disease. Front Immunol. 2022; 13:873985.

View in: PubMed
Riding RL, Richmond JM, Fukuda K, Harris JE. Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy. Pigment Cell Melanoma Res. 2021 07; 34(4):683-695.

View in: PubMed
Groover MK, Richmond JM. Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases. F1000Res. 2020; 9:1197.

View in: PubMed
Pontes Ferreira C, Moro Cariste L, Henrique Noronha I, Fernandes Durso D, Lannes-Vieira J, Ramalho Bortoluci K, Araki Ribeiro D, Golenbock D, Gazzinelli RT, Vasconcelos JRC. CXCR3 chemokine receptor contributes to specific CD8+?T cell activation by pDC during infection with intracellular pathogens. PLoS Negl Trop Dis. 2020 06; 14(6):e0008414.

View in: PubMed
Dobson HE, Dias LDS, Kohn EM, Fites S, Wiesner DL, Dileepan T, Kujoth GC, Abraham A, Ostroff GR, Klein BS, W?thrich M. Antigen discovery unveils resident memory and migratory cell roles in antifungal resistance. Mucosal Immunol. 2020 05; 13(3):518-529.

View in: PubMed
Hirako IC, Assis PA, Galv?o-Filho B, Luster AD, Antonelli LR, Gazzinelli RT. Monocyte-derived dendritic cells in malaria. Curr Opin Microbiol. 2019 12; 52:139-150.

View in: PubMed
Pontes Ferreira C, Cariste LM, Ferri Moraschi B, Ferrarini Zanetti B, Won Han S, Araki Ribeiro D, Vieira Machado A, Lannes-Vieira J, Gazzinelli RT, Vasconcelos JRC. CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge. PLoS Negl Trop Dis. 2019 07; 13(7):e0007597.

View in: PubMed
Jeyanathan M, Afkhami S, Khera A, Mandur T, Damjanovic D, Yao Y, Lai R, Haddadi S, Dvorkin-Gheva A, Jordana M, Kunkel SL, Xing Z. CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway. J Immunol. 2017 10 01; 199(7):2555-2569.

View in: PubMed
Strassner JP, Rashighi M, Ahmed Refat M, Richmond JM, Harris JE. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 2017 May; 76(5):847-855.e5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals